Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Pivotal Bioventure Partners Investment Advisor Llc > Profile

Instuitional Investor - Pivotal Bioventure Partners Investment Advisor Llc

Fund Profile
Filing Period:
Fund Name: Pivotal Bioventure Partners Investment Advisor Llc
Portfolio Value $307,788,414
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Vaxcyte Inc.
 PCVX 1,425,470 $82,862,571 26.92%
2.
Arcutis Biotherapeutics Inc.
 ARQT 1,265,283 $33,175,720 10.78%
3.
Trevi Therapeutics Inc.
 TRVI 1,742,672 $32,500,833 10.56%
4.
Avalyn Pharmaceuticals Inc
 966,792 $31,826,793 10.34%
5.
Evommune Inc
 1,926,943 $25,609,072 8.32%
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.